---
title: "HUADONG MEDICINE's innovative GLP-1/GIP dual-target long-acting agonist Pralmorelin injection's new veterinary drug registration application has been accepted by the Ministry of Agriculture and Rural Affairs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/270972787.md"
description: "Huadong Medicine Co., Ltd.'s wholly-owned subsidiary Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. received the \"Acceptance Notice\" from the Ministry of Agriculture and Rural Affairs on December 26, and its application for the market registration of the new veterinary drug Prucalopride Injection has been accepted, with the indication for weight management in adult obese cats"
datetime: "2025-12-29T09:10:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/270972787.md)
  - [en](https://longbridge.com/en/news/270972787.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/270972787.md)
generator: "portal-rs"
---

# HUADONG MEDICINE's innovative GLP-1/GIP dual-target long-acting agonist Pralmorelin injection's new veterinary drug registration application has been accepted by the Ministry of Agriculture and Rural Affairs

On December 26th, Huadong Medicine Co., Ltd.'s wholly-owned subsidiary Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. received the "Acceptance Notice" issued by the Ministry of Agriculture and Rural Affairs of the People's Republic of China (Pralmorelin Injection Acceptance Number: 07050020250624-8, Pralmorelin Acceptance Number: 07050020250619-2). The application for the registration of the new veterinary drug Pralmorelin Injection under the HDM7006 project has been accepted, with the declared indication being: weight management for adult obese cats

### Related Stocks

- [000963.CN](https://longbridge.com/en/quote/000963.CN.md)

## Related News & Research

- [CARsgen FY26 H1 net loss narrows to RMB 70.84 million; revenue rises 21.49% to RMB 61.92 million](https://longbridge.com/en/news/296243257.md)
- [Oura exploring how its ring could detect brain hemorrhages after Bill Ackman suggests it could have helped his daughter](https://longbridge.com/en/news/296658401.md)
- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [Stocks in Play: Metro Inc.](https://longbridge.com/en/news/296508762.md)
- [Multicoin Capital-Linked Wallet Transfers 197,560 HYPE to CEX, Raising Sale Concerns](https://longbridge.com/en/news/296661501.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**